Insulin

Insulin is a peptide hormone synthesized and secreted by beta cells of the pancreatic islets. It is one of the most important regulators of nutrient metabolism and is the principal hormone responsible for lowering blood glucose after carbohydrate-containing meals.

Insulin coordinates the transition from the fasting state to the fed state. When circulating glucose and other nutrients increase after a meal, pancreatic beta cells increase insulin secretion. Insulin then promotes glucose utilization and storage while directing amino acids and fatty acids toward anabolic pathways.

The actions of insulin extend well beyond glucose regulation. It stimulates glycogen synthesis, lipid storage, and protein synthesis while suppressing hepatic glucose production, lipolysis, proteolysis, and ketogenesis. Insulin therefore functions as a major anabolic hormone that signals nutrient availability to tissues throughout the body.

Hormone Classification

Insulin is a peptide hormone consisting of two polypeptide chains, the A chain and B chain, connected by disulfide bonds.

Because insulin is peptide-based, it is stored within secretory granules and released by exocytosis. Its receptor is located on the cell surface.

Site of Insulin Production

Insulin is produced by beta cells within the pancreatic islets, traditionally called the islets of Langerhans.

These endocrine structures are distributed throughout the pancreas and are closely associated with a dense network of fenestrated capillaries that permits rapid sensing of circulating nutrients and rapid hormone delivery into the bloodstream.

Pancreatic Islets

The pancreatic islets are microscopic endocrine cell clusters embedded within the predominantly exocrine pancreas.

Each islet contains several endocrine cell populations that interact through endocrine, paracrine, and neural mechanisms to regulate nutrient metabolism.

Major Pancreatic Islet Cells

Cell Type	Major Hormone	Major Role
Beta cells	Insulin	Promote nutrient utilization and storage
Alpha cells	Glucagon	Promote hepatic glucose production
Delta cells	Somatostatin	Modulate neighboring endocrine cells
PP cells	Pancreatic polypeptide	Participate in gastrointestinal and pancreatic regulation

Beta Cells

Beta cells are specialized endocrine cells responsible for insulin synthesis, storage, and secretion.

They respond particularly strongly to changes in circulating glucose but also integrate signals from amino acids, gastrointestinal hormones, autonomic nerves, and neighboring islet cells.

Islet Vascular Supply

Pancreatic islets possess a rich capillary network. This vascular arrangement allows beta cells to rapidly detect changes in blood nutrient concentrations and permits newly secreted insulin to quickly enter the circulation.

The close association between endocrine cells and capillaries is a fundamental structural feature of pancreatic endocrine tissue.

Insulin Synthesis

Insulin is initially synthesized as a larger precursor called preproinsulin.

Processing through the rough endoplasmic reticulum, Golgi apparatus, and secretory granules converts this precursor into mature insulin.

Preproinsulin

Preproinsulin contains an N-terminal signal peptide that directs the newly synthesized protein into the rough endoplasmic reticulum.

Removal of the signal peptide produces proinsulin.

Proinsulin

Proinsulin is a single polypeptide containing the future A chain, B chain, and connecting peptide.

Folding of proinsulin permits formation of the disulfide bonds that ultimately connect the A and B chains of mature insulin.

C-Peptide

Within secretory granules, proinsulin is cleaved to form mature insulin and C-peptide.

Insulin and C-peptide are released together from pancreatic beta cells. Measurement of C-peptide can therefore provide information about endogenous insulin secretion.

Insulin Processing

Stage	Major Event
Preproinsulin	Initial translation product containing a signal peptide
Proinsulin	Signal peptide removed and molecule folded
Insulin + C-peptide	Proinsulin cleaved within secretory granules
Secretion	Insulin and C-peptide released from beta cells

Structure of Mature Insulin

Mature human insulin contains an A chain of 21 amino acids and a B chain of 30 amino acids.

The two chains are connected by disulfide bonds, with an additional intrachain disulfide bond within the A chain.

Insulin Storage

Mature insulin is stored within membrane-bound secretory granules in pancreatic beta cells.

These granules can undergo regulated exocytosis when beta cells detect appropriate metabolic and neuroendocrine signals.

Glucose-Stimulated Insulin Secretion

An increase in circulating glucose is the most important physiological stimulus for insulin secretion.

Beta cells couple glucose metabolism to electrical activity and calcium-dependent exocytosis, allowing insulin secretion to closely reflect nutrient availability.

Beta Cell Glucose Sensing

Glucose enters beta cells through glucose transport mechanisms and undergoes metabolism. Increasing glucose metabolism raises the intracellular ATP-to-ADP ratio.

This metabolic change is translated into electrical activity through ATP-sensitive potassium channels.

ATP-Sensitive Potassium Channels

ATP-sensitive potassium channels (KATP channels) connect beta-cell metabolism with membrane excitability.

As intracellular ATP rises, KATP channels close, reducing potassium efflux and causing membrane depolarization.

Voltage-Gated Calcium Channels

Beta-cell membrane depolarization opens voltage-gated calcium channels.

The resulting calcium influx raises intracellular calcium and triggers exocytosis of insulin-containing secretory granules.

Glucose-Stimulated Secretion Sequence

Step	Event
1	Blood glucose rises
2	Beta-cell glucose metabolism increases
3	Intracellular ATP-to-ADP ratio rises
4	ATP-sensitive potassium channels close
5	Beta-cell membrane depolarizes
6	Voltage-gated calcium channels open
7	Intracellular calcium increases
8	Insulin granules undergo exocytosis

Biphasic Insulin Secretion

When beta cells are exposed to a sustained rise in glucose, insulin secretion can display a biphasic pattern.

An initial rapid phase reflects release from a readily releasable pool of insulin granules. A more sustained second phase involves continued mobilization and secretion of additional granules.

Incretin Effect

Oral glucose generally stimulates a greater insulin response than an equivalent glucose exposure delivered directly into the circulation. This phenomenon is called the incretin effect.

It results largely from gastrointestinal hormones released in response to nutrient ingestion.

GLP-1

Glucagon-like peptide-1 (GLP-1) is an incretin hormone released primarily from intestinal enteroendocrine L cells.

GLP-1 enhances glucose-dependent insulin secretion and also participates in regulation of glucagon secretion, gastric emptying, and appetite.

GIP

Glucose-dependent insulinotropic polypeptide (GIP) is another major incretin hormone.

It is released from intestinal K cells in response to nutrient ingestion and enhances glucose-dependent insulin secretion from pancreatic beta cells.

Major Stimulators of Insulin Secretion

Stimulus	Effect
Glucose	Major physiological stimulus
Amino acids	Can stimulate insulin secretion
GLP-1	Enhances glucose-dependent secretion
GIP	Enhances glucose-dependent secretion
Parasympathetic activity	Can promote meal-related insulin secretion

Autonomic Regulation

The autonomic nervous system modulates pancreatic beta-cell secretion.

Parasympathetic signaling contributes to anticipatory and meal-related insulin release, while sympathetic signaling can modify secretion during stress and exercise.

Insulin Receptor

Insulin acts through the insulin receptor, a transmembrane receptor with intrinsic tyrosine kinase activity.

The receptor is expressed by many tissues, including skeletal muscle, adipose tissue, and liver.

Insulin Receptor Structure

The mature insulin receptor consists of extracellular alpha subunits and transmembrane beta subunits linked by disulfide bonds.

Insulin binds to the extracellular portion of the receptor, activating tyrosine kinase activity in the intracellular portion.

Insulin Receptor Signaling

Insulin binding causes receptor autophosphorylation and phosphorylation of intracellular proteins, including insulin receptor substrates (IRS proteins).

These proteins initiate several downstream signaling pathways responsible for insulin's metabolic, growth-promoting, and gene-regulatory effects.

PI3K-Akt Pathway

The PI3K-Akt pathway mediates many of insulin's major metabolic actions.

Among its effects are stimulation of GLUT4 translocation, glycogen synthesis, protein synthesis, and other anabolic processes.

Insulin Signaling Sequence

Step	Event
1	Insulin binds the insulin receptor
2	Receptor tyrosine kinase activity increases
3	Insulin receptor substrates are phosphorylated
4	PI3K and downstream signaling pathways are activated
5	Akt and other signaling proteins regulate metabolic targets
6	Glucose transport, nutrient storage, and anabolic pathways increase

Major Target Tissues

Insulin acts on numerous tissues, but its metabolic effects are particularly important in the liver, skeletal muscle, and adipose tissue.

Tissue	Major Insulin Actions
Liver	Promotes glycogen synthesis and lipogenesis while suppressing glucose production and ketogenesis
Skeletal muscle	Increases glucose uptake, glycogen synthesis, amino acid uptake, and protein synthesis
Adipose tissue	Increases glucose uptake and triglyceride storage while suppressing lipolysis

GLUT4

GLUT4 is an insulin-responsive glucose transporter expressed prominently in skeletal muscle and adipose tissue.

In the absence of strong insulin stimulation, much of the cellular GLUT4 pool is maintained within intracellular vesicles. Insulin signaling causes these vesicles to move toward and fuse with the plasma membrane.

GLUT4 Translocation

Insertion of GLUT4 into the plasma membrane increases the capacity of skeletal muscle and adipose cells to transport glucose from the extracellular fluid into the cytoplasm.

When insulin signaling declines, GLUT4 transporters can be internalized again into intracellular compartments.

Insulin and Skeletal Muscle

Skeletal muscle is a major site of insulin-stimulated glucose disposal after meals.

Insulin increases GLUT4-mediated glucose uptake and promotes conversion of intracellular glucose into glycogen or its utilization for energy.

Muscle Glycogen

Insulin promotes glycogen synthesis in skeletal muscle.

Muscle glycogen serves primarily as a local energy reserve for muscle contraction rather than as a direct source of glucose released into the bloodstream.

Insulin and Protein Metabolism

Insulin promotes amino acid uptake and protein synthesis while reducing protein breakdown.

These actions contribute to its overall anabolic role, particularly in conjunction with adequate nutrient and amino acid availability.

Insulin and Adipose Tissue

Insulin promotes energy storage in adipose tissue by increasing glucose utilization and favoring triglyceride synthesis.

It also strongly suppresses mobilization of stored triglycerides.

Insulin and Lipoprotein Lipase

Insulin promotes activity of lipoprotein lipase in adipose tissue, facilitating uptake of fatty acids derived from circulating triglyceride-rich lipoproteins.

These fatty acids can subsequently be re-esterified and stored as triglycerides.

Insulin and Lipolysis

Insulin suppresses lipolysis within adipocytes.

This reduces release of nonesterified fatty acids and glycerol from adipose stores during the fed state.

Hormone-Sensitive Lipase

Insulin inhibits pathways that activate hormone-sensitive lipase and other components of adipocyte lipolysis.

Reduced lipolytic activity helps preserve stored triglycerides when dietary nutrients are abundant.

Insulin and the Liver

The liver is a major target of insulin, although hepatic glucose entry itself is not dependent on GLUT4.

Insulin changes hepatic enzyme activity and gene expression to favor glucose storage and utilization while suppressing endogenous glucose production.

Hepatic Glycogen Synthesis

Insulin stimulates hepatic glycogen synthesis and suppresses glycogen breakdown.

This allows excess glucose arriving after a meal to be temporarily stored as hepatic glycogen.

Hepatic Glycolysis

Insulin favors hepatic glycolysis during the fed state.

This promotes utilization of glucose and provides intermediates that can contribute to energy production and lipid synthesis.

Gluconeogenesis

Insulin suppresses hepatic gluconeogenesis, reducing synthesis of glucose from lactate, glycerol, and amino acid-derived substrates.

This is one of the major mechanisms by which insulin decreases hepatic glucose output.

Hepatic Glycogenolysis

Insulin inhibits hepatic glycogenolysis.

By simultaneously increasing glycogen synthesis and reducing glycogen breakdown, insulin shifts hepatic carbohydrate metabolism toward storage.

Hepatic Glucose Production

Suppression of hepatic glucose production is a major physiological action of insulin.

Insulin reduces both gluconeogenesis and glycogenolysis, preventing unnecessary release of endogenous glucose when circulating nutrients are abundant.

Lipogenesis

When carbohydrate availability exceeds immediate energy and glycogen-storage requirements, insulin favors conversion of excess substrate into fatty acids.

This process contributes to de novo lipogenesis and long-term energy storage as triglyceride.

Insulin and Ketogenesis

Insulin strongly suppresses ketogenesis.

By inhibiting adipose lipolysis and altering hepatic metabolism, insulin reduces the supply and utilization of fatty acids for excessive ketone body production.

Major Metabolic Effects of Insulin

Metabolic Process	Effect of Insulin
Muscle and adipose glucose uptake	Increases
Glycogen synthesis	Increases
Hepatic glucose production	Decreases
Gluconeogenesis	Decreases
Glycogenolysis	Decreases
Lipogenesis	Increases
Lipolysis	Decreases
Ketogenesis	Decreases
Protein synthesis	Increases
Proteolysis	Decreases

Insulin and Potassium

Insulin promotes movement of potassium into cells, particularly skeletal muscle cells.

This effect has important physiological and clinical implications because insulin can rapidly lower extracellular potassium concentrations without removing potassium from the body.

Sodium-Potassium ATPase

Insulin increases cellular potassium uptake partly through effects involving the sodium-potassium ATPase.

The resulting shift of potassium from extracellular fluid into cells is independent of insulin's glucose-lowering action.

Insulin and Hyperkalemia

Because insulin shifts potassium into cells, insulin administered with glucose can be used clinically to temporarily reduce dangerously elevated extracellular potassium concentrations.

This redistributes potassium but does not eliminate excess potassium from the body.

Fed State

The fed state is characterized by increased nutrient availability and generally increased insulin secretion.

Insulin directs incoming nutrients toward immediate utilization and storage, limiting unnecessary mobilization of endogenous energy reserves.

Insulin During Fasting

Insulin concentrations decline during fasting as circulating glucose and nutrient availability decrease.

Reduced insulin signaling permits hepatic glucose production, adipose lipolysis, and other pathways required to mobilize stored fuels.

Insulin-to-Glucagon Ratio

The balance between insulin and glucagon helps determine whether metabolism favors nutrient storage or fuel mobilization.

A relatively high insulin-to-glucagon ratio characterizes the fed state, while a lower ratio favors fasting metabolism.

Fed Versus Fasting Metabolism

Feature	Fed State	Fasting State
Insulin	Higher	Lower
Relative glucagon activity	Lower	Higher
Glycogen synthesis	Favored	Reduced
Hepatic glucose production	Suppressed	Increased
Lipogenesis	Favored	Reduced
Lipolysis	Suppressed	Increased
Ketogenesis	Suppressed	Can increase

Insulin Versus Glucagon

Feature	Insulin	Glucagon
Pancreatic source	Beta cells	Alpha cells
Major metabolic signal	Nutrient abundance	Fasting and falling glucose
Blood glucose effect	Lowers	Raises
Hepatic glycogen synthesis	Stimulates	Inhibits
Hepatic glycogenolysis	Inhibits	Stimulates
Gluconeogenesis	Inhibits	Stimulates
Ketogenesis	Inhibits	Favored when glucagon predominates over insulin
Overall tendency	Anabolic and storage-promoting	Fuel mobilization

Insulin and the Brain

Most glucose uptake across the blood-brain barrier and into neurons does not require insulin-dependent GLUT4 translocation.

Insulin nevertheless has signaling functions within the central nervous system and participates in regulation of metabolism and energy balance.

Insulin and Red Blood Cells

Glucose uptake by red blood cells is largely insulin-independent.

These cells rely on constitutively expressed glucose transport mechanisms and metabolize glucose primarily through anaerobic glycolysis.

Insulin-Dependent and Insulin-Independent Glucose Uptake

Tissue	Relationship to Insulin for Glucose Uptake
Skeletal muscle	Strong insulin-responsive GLUT4 component
Adipose tissue	Strong insulin-responsive GLUT4 component
Liver	Glucose transport not dependent on GLUT4, but metabolism strongly regulated by insulin
Brain	Major glucose uptake largely insulin-independent
Red blood cells	Insulin-independent glucose uptake

Insulin Resistance

Insulin resistance is a state in which target tissues show a reduced biological response to a given concentration of insulin.

It commonly affects skeletal muscle, liver, and adipose tissue and can increase the amount of insulin required to maintain normal glucose homeostasis.

Compensatory Hyperinsulinemia

When insulin resistance develops, pancreatic beta cells may initially compensate by increasing insulin secretion.

This compensatory hyperinsulinemia can maintain blood glucose within or near the normal range for a period of time despite reduced insulin sensitivity.

Type 1 Diabetes Mellitus

Type 1 diabetes mellitus is characterized by autoimmune destruction of pancreatic beta cells, resulting in severe or absolute insulin deficiency.

Loss of insulin disrupts glucose utilization and removes restraint on hepatic glucose production, lipolysis, and ketogenesis.

Type 2 Diabetes Mellitus

Type 2 diabetes mellitus is characterized by insulin resistance together with progressive dysfunction of pancreatic beta cells.

As beta-cell compensation becomes inadequate relative to insulin resistance, persistent hyperglycemia develops.

Insulin Deficiency

Insulin deficiency produces a shift from anabolic metabolism toward uncontrolled fuel mobilization.

Hepatic glucose production increases, peripheral glucose utilization becomes impaired in insulin-sensitive tissues, adipose lipolysis increases, and excessive ketone production may occur when insulin deficiency is severe.

Diabetic Ketoacidosis

Diabetic ketoacidosis (DKA) is a severe metabolic complication caused primarily by marked insulin deficiency together with increased counter-regulatory hormone activity.

Accelerated lipolysis supplies fatty acids to the liver, where increased oxidation and ketogenesis generate large quantities of acidic ketone bodies.

Insulin and Hypoglycemia

Excess insulin relative to circulating glucose availability can cause hypoglycemia.

The body responds by reducing endogenous insulin secretion and activating counter-regulatory mechanisms involving glucagon, catecholamines, and other hormones.

Insulinoma

An insulinoma is a pancreatic neuroendocrine tumor that secretes insulin inappropriately.

Excessive insulin secretion can produce recurrent episodes of hypoglycemia, particularly during fasting.

Endogenous Versus Exogenous Insulin

Endogenous insulin produced by pancreatic beta cells is secreted together with C-peptide.

Standard therapeutic insulin preparations do not contain C-peptide. Measurement of insulin together with C-peptide can therefore help distinguish endogenous insulin secretion from administered insulin in selected clinical settings.

C-Peptide Measurement

C-peptide is often useful as a marker of residual beta-cell function.

Because endogenous insulin and C-peptide are produced in equimolar amounts during proinsulin processing, circulating C-peptide provides information about the body's own insulin secretion.

Insulin Clearance

Insulin is removed from the circulation primarily by the liver and kidneys.

Because pancreatic venous blood reaches the liver through the portal circulation, the liver is exposed to relatively high concentrations of endogenous insulin and removes a substantial fraction during first passage.

Portal Insulin Delivery

Endogenous pancreatic insulin enters the hepatic portal circulation before reaching the systemic circulation.

This anatomical arrangement exposes the liver to higher insulin concentrations than many peripheral tissues and supports insulin's central role in controlling hepatic glucose production.

Insulin and the Portal Circulation

Step	Event
1	Beta cells release insulin into islet capillaries
2	Pancreatic venous blood drains toward the portal venous system
3	The liver receives a high concentration of newly secreted insulin
4	Hepatic insulin signaling suppresses glucose production and promotes storage
5	Remaining insulin reaches the systemic circulation and peripheral tissues

Insulin Therapy

Insulin is an essential therapy for people with type 1 diabetes and is also used in many people with type 2 diabetes and other forms of diabetes when endogenous insulin secretion is inadequate for metabolic needs.

Therapeutic insulin preparations differ in onset, peak activity, and duration, allowing treatment regimens to approximate basal and meal-related insulin requirements.

Basal Insulin

Basal insulin is intended to provide background insulin activity between meals and overnight.

Physiologically, basal insulin restrains excessive hepatic glucose production and uncontrolled lipolysis during periods without food intake.

Prandial Insulin

Prandial insulin is used to address the rise in glucose associated with meals.

It approximates the physiological increase in beta-cell insulin secretion that normally follows nutrient ingestion.

Key Anatomical Pathway

Anatomical Level	Role
Pancreatic islet	Contains insulin-producing beta cells
Beta cell	Synthesizes, stores, and secretes insulin
Islet capillaries	Receive secreted insulin
Portal circulation	Delivers endogenous insulin first to the liver
Liver	Suppresses glucose production and promotes nutrient storage
Systemic circulation	Distributes insulin to peripheral tissues
Skeletal muscle	Increases glucose uptake and glycogen and protein synthesis
Adipose tissue	Increases glucose uptake and triglyceride storage and suppresses lipolysis

Key Features of Insulin

Feature	Key Point
Hormone class	Peptide hormone
Primary source	Pancreatic beta cells
Precursor	Preproinsulin, then proinsulin
Major secretory products	Insulin and C-peptide
Major stimulus	Increased blood glucose
Receptor	Receptor tyrosine kinase
Major metabolic signaling pathway	IRS, PI3K and Akt
Major target tissues	Liver, skeletal muscle and adipose tissue
Glucose effect	Lowers circulating glucose
GLUT4 effect	Promotes translocation in skeletal muscle and adipose tissue
Hepatic glucose production	Suppresses
Glycogen synthesis	Stimulates
Lipolysis	Suppresses
Ketogenesis	Suppresses
Protein synthesis	Promotes
Overall metabolic role	Anabolic and nutrient-storage hormone

Anatomical and Physiological Importance

Insulin connects the microscopic organization of the endocrine pancreas with whole-body nutrient metabolism. Beta cells within pancreatic islets are positioned beside a dense capillary network and continuously monitor circulating nutrients. When glucose availability increases, beta-cell metabolism generates the electrical and calcium signals required for rapid insulin secretion.

Newly secreted endogenous insulin reaches the liver through the portal circulation before entering the systemic circulation. This anatomical arrangement is particularly important because the liver is a major regulator of circulating glucose. Insulin suppresses hepatic glycogenolysis and gluconeogenesis while promoting glycogen synthesis and nutrient storage.

In peripheral tissues, insulin coordinates additional aspects of the fed state. Skeletal muscle increases GLUT4-mediated glucose uptake and stores glucose as glycogen while increasing protein synthesis. Adipose tissue increases glucose utilization and triglyceride storage while suppressing release of stored fatty acids.

These effects are mediated through the insulin receptor, a receptor tyrosine kinase that activates intracellular signaling networks including the IRS-PI3K-Akt pathway. In skeletal muscle and adipose tissue, one of the most important consequences is movement of GLUT4-containing vesicles to the plasma membrane, greatly increasing cellular glucose uptake.

Insulin also determines whether the body remains in an anabolic state or shifts toward mobilization of stored fuels. Falling insulin during fasting permits hepatic glucose production and adipose lipolysis. Severe insulin deficiency removes these restraints almost completely, producing hyperglycemia, accelerated lipolysis, and potentially excessive ketogenesis.

Through its synthesis by pancreatic beta cells, nutrient-responsive secretion, portal delivery to the liver, receptor tyrosine kinase signaling, stimulation of glucose uptake and nutrient storage, suppression of hepatic glucose production and lipolysis, and close functional relationship with glucagon, insulin is a central endocrine regulator of glucose and energy homeostasis.